Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

Area of Science:

• Cardiology
• Geriatric Medicine
• Clinical Trials

Background:

• Clinical guidelines recommend invasive management for non-ST-segment elevation myocardial infarction (NSTEMI).
• This strategy is underutilized in frail elderly patients due to limited clinical trial data.
• Frail elderly patients are often underrepresented in cardiovascular research.

Purpose of the Study:

• To test the hypothesis that an invasive strategy improves prognosis in elderly frail patients diagnosed with NSTEMI.
• To provide evidence to inform the management of NSTEMI in a vulnerable, understudied patient group.
• To determine if frailty status should influence the decision for invasive cardiac procedures.

Main Methods:

• Prospective, multicenter randomized trial comparing conservative and invasive strategies.
• Inclusion criteria: NSTEMI diagnosis, age ≥ 70 years, and Clinical Frailty Scale score ≥ 4.
• Randomization to invasive (angiogram and revascularization) or conservative (medical management) arms.

Main Results:

• The study aims to add crucial knowledge regarding the management of frail elderly patients with NSTEMI.
• Primary endpoint: days alive out of hospital in the first year.
• Coprimary endpoint: time to first major adverse cardiac event (cardiac death, reinfarction, revascularization).

Conclusions:

• The study hypothesizes that an invasive strategy will lead to better outcomes for frail elderly patients with NSTEMI.
• If confirmed, findings suggest that frailty should not be a barrier to pursuing invasive management.
• Results will help bridge the evidence gap for this specific patient demographic.